Study Phase 3

A Phase 3, Multi-Center, Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam versus vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia)

Trial Information

Generic NameMinoxidil 5% Women's FoamProduct NameRogaine 5% Women's FoamTherapeutic AreaDermatologicalsProduct ClassOther Dermatological PreparationsPharmacological SubgroupOther Dermatological PreparationsChemical SubgroupOther DermatologicalsCondition StudiedAlopecia, Androgenetic
Sponsor Protocol NumberMINALO3005Enrollment404Data PartnerJohnson & Johnson% Female100%Mean/Median Age (Years)55.5% White70.5%

Supporting Documentation

  • Collected Datasets Available
  • Data Definition Specification Available
  • Protocol with Amendments Available
  • Statistical Analysis Plan Available
  • Clinical Study Report Available

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.